For investors seeking momentum, iShares S&P 500 Growth ETF (IVW - Free Report) is probably on radar now. The fund just hit a 52-week high and is up more than 21% from its 52-week low price of $105.46/share.
But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed:
IVW in Focus
IVW provides exposure to large cap stocks whose earnings are expected to grow at an above-average rate relative to the market. Holding 319 stocks, it is moderately concentrated across securities with none holding more than 6.61% share. The fund has key holdings in information technology while consumer discretionary, healthcare and industrials round off the next three spots. It charges 18 basis points in annual fees (see: all the Large Cap ETFs here).
Why the Move?
The growth space of the broad U.S. stock market has been an area to watch lately given that U.S. bourses hit multiple highs again and logged in the third weekly gain. The optimism strengthened following Trump’s talks of tax cuts and infrastructure spending that reignited a post-election rally, which had stalled on concerns over Trump’s protectionist action and lack of clarity on policy reforms. In such a trending market (i.e. a market characterized by a prolonged uptrend), growth stocks tend to outperform.
More Gains Ahead?
Currently, IVW has a Zacks ETF Rank of 3 or ‘Hold’ rating with a Medium risk outlook. Therefore, it is hard to get a handle on its future returns one way or the other. However, many of the segments that make up this ETF have a strong Zacks Industry Rank, so there is definitely some promise for those who want to ride this surging ETF a little further.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
For investors seeking momentum, iShares S&P 500 Growth ETF (IVW - Free Report) is probably on radar now. The fund just hit a 52-week high and is up more than 21% from its 52-week low price of $105.46/share.
But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed:
IVW in Focus
IVW provides exposure to large cap stocks whose earnings are expected to grow at an above-average rate relative to the market. Holding 319 stocks, it is moderately concentrated across securities with none holding more than 6.61% share. The fund has key holdings in information technology while consumer discretionary, healthcare and industrials round off the next three spots. It charges 18 basis points in annual fees (see: all the Large Cap ETFs here).
Why the Move?
The growth space of the broad U.S. stock market has been an area to watch lately given that U.S. bourses hit multiple highs again and logged in the third weekly gain. The optimism strengthened following Trump’s talks of tax cuts and infrastructure spending that reignited a post-election rally, which had stalled on concerns over Trump’s protectionist action and lack of clarity on policy reforms. In such a trending market (i.e. a market characterized by a prolonged uptrend), growth stocks tend to outperform.
More Gains Ahead?
Currently, IVW has a Zacks ETF Rank of 3 or ‘Hold’ rating with a Medium risk outlook. Therefore, it is hard to get a handle on its future returns one way or the other. However, many of the segments that make up this ETF have a strong Zacks Industry Rank, so there is definitely some promise for those who want to ride this surging ETF a little further.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on IVW - FREE